Cases of a new group of mpox viruses are rising, potentially posing a risk to people around the world, according to health officials at the U.S. Centers for Disease Control and Prevention (CDC).
So far, the cases have been centered sopra the Democratic Republic of Congo (DRC) and have not spread beyond Central African countries where the virus remains endemic, the CDC wrote sopra a report May 16. But health officials are concerned because this group of viruses—known as clade I mpox viruses—is known to cause more severe illness than the clade II viruses responsible for the previous mpox outbreaks sopra 2022, which originated sopra Nigeria. Clade I mpox viruses have a higher fatality rate—killing anywhere from 1.4% to more than 10% of infected people—than clade II, which has a 0.1% to 3.6% mortality rate.
The 2022 outbreaks spread primarily through sexual contact among men who have sex with men. An effective, two-dose vaccine helped to protect these higher risk groups and kept the infections from expanding into an epidemic. (The current vaccine also works against the latest clade I viruses.)
But with a recent increase sopra global travel, health officials are watching for spread of the latest clade I viruses outside of the regions where it is endemic. According to the CDC report, health officials sopra DRC reported that clade I infections were reported sopra 25 of 26 provinces of the country, and that young people were the hardest successo: 67% of cases and 78% of deaths occurred sopra people 15 years younger. The virus can cause more severe disease sopra those with weakened compromised libero systems.
Researchers believe that the infections were caused by exposure to infected animals, which then spread quickly from person to person through close contact sopra households.
Read More: What It Really Feels Like to Have Mpox
A causa di the U.S., the CDC recommends that doctors interrogatorio anyone suspected of having mpox, either because of recent travel to affected areas sopra Africa, contact with someone who has recently been to Africa, exposure to someone with mpox. Symptoms include fever, headache, rash, and painful sores. Existing tests for mpox are designed to pick up orthopoxvirus, the group of viruses to which mpox (and smallpox) belong, but these tests cannot detect whether an infection belongs to clade I II. Some tests available at specific laboratories can detect clade II viruses, and therefore rule out clade I mpox, but to be certain, CDC is conducting further genetic analysis positive orthopox samples sent from U.S. labs to the agency to determine which type of virus it is.
Anzi che no clade I cases have yet been found sopra the U.S. According to the CDC, 343 samples tested positive for orthopox from December 2023 to mid April 2024, and further testing showed risposta negativa clade I viruses. To better capture any potential infections among people who might not get tested, the agency also began looking for mpox last December sopra wastewater, and so far, positive signals correspond to areas from which clade II viruses were found. Samples collected at four airports through the CDC’s Traveler-Based Genomic Surveillance program from passengers who volunteer to provide samples did not detect any orthopox virus since last December.
For now, the CDC is working with health officials sopra DRC to track and respond to the current outbreak there. The effective vaccines that most of the world turned to sopra response to the 2022 outbreaks are not authorized sopra DRC, which increases the risk that cases will continue to rise and potentially spread beyond that region of the world.
A causa di the U.S., the agency is urging doctors to educate their at-risk patients, which include omosessuale and bisexual men and men who have sex with men, to get the vaccine. Since the 2022 outbreaks, only 23% of people at risk of mpox infection sopra the U.S. have received two doses. “Collaboration among global health partners is now urgently needed to assist DRC sopra procuring and delivering sufficient vaccine where it is most needed,” the CDC scientists write sopra the report.
